en
Scientific article
Open access
English

No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?

Published inPLOS ONE, vol. 12, no. 4, e0174797
Publication date2017
Abstract

The 22q11.2 deletion syndrome (22q11DS) is one of the highest known risk factors for schizophrenia. Thus, the detection of 22q11DS patients at particularly high risk of psychosis is important, yet studies on the clinical significance of the widely used ultra-high risk (UHR) criteria in 22q11DS are inconclusive. Since age was reported to moderate clinical significance of UHR symptoms in community samples, we explored whether age at presentation of UHR symptoms and criteria may explain part of this heterogeneity.

Keywords
  • 22q11 Deletion Syndrome/genetics/physiopathology/psychology
  • Adolescent
  • Adult
  • Age Factors
  • Age of Onset
  • Child
  • Female
  • Humans
  • Male
  • Psychotic Disorders/genetics/physiopathology/psychology
  • Schizophrenia/genetics/physiopathology
Citation (ISO format)
ARMANDO, Marco et al. No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis? In: PLOS ONE, 2017, vol. 12, n° 4, p. e0174797. doi: 10.1371/journal.pone.0174797
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1932-6203
441views
183downloads

Technical informations

Creation09/21/2017 4:59:00 PM
First validation09/21/2017 4:59:00 PM
Update time03/15/2023 2:03:24 AM
Status update03/15/2023 2:03:23 AM
Last indexation02/12/2024 11:28:20 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack